Study Points to Role of ABCB1 Gene Alterations in Plavix-Treated Patients' Cardiovascular AEs | GenomeWeb

By Turna Ray

New analysis of the TRITON-TIMI 38 study presented at the American College of Cardiology's annual meeting this week adds to a growing body of pharmacogenomic knowledge on why certain patients treated with Plavix experience increased cardiovascular adverse reactions.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PLOS this week: transcriptional and translational study of human cytomegalovirus interactions with host cells, spider web DNA study, and more.

The New York Stem Cell Foundation signs a lease for a new space.

Researchers gear up for an international meeting to discuss the ethics of gene editing.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.